What is the summary of the GAS (General Anesthesia Study) and PANDA (Pediatric Anesthesia NeuroDevelopment Assessment) trials regarding neurodevelopmental outcomes after early childhood exposure to general anesthesia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

GAS and PANDA Trials: Summary of Key Findings

Both the GAS and PANDA trials provide reassuring evidence that a single, brief exposure to general anesthesia in early childhood does not cause clinically significant neurodevelopmental harm at age 5 years.

The GAS Trial (General Anesthesia compared to Spinal anesthesia)

The GAS trial was an international, prospective, randomized controlled equivalence trial comparing awake-regional anesthesia versus sevoflurane-based general anesthesia in infants undergoing inguinal herniorrhaphy 1, 2.

Study Design

  • Population: Infants <60 weeks postmenstrual age, born >26 weeks gestation
  • Intervention: Randomized 1:1 to awake-regional vs. sevoflurane general anesthesia
  • Median anesthesia duration: 54 minutes
  • Primary outcome: Full-scale IQ (FSIQ) at age 5 years using WPPSI-III
  • Secondary outcome: Bayley Scales cognitive score at age 2 years

Key Results at Age 2 Years

  • Cognitive composite scores were equivalent between groups (98.6 in awake-regional vs. 98.2 in general anesthesia)
  • Mean difference: 0.169 (95% CI: -2.30 to 2.64), demonstrating equivalence 1

Key Results at Age 5 Years (Primary Outcome)

  • Mean FSIQ scores were clinically equivalent: 99.08 in awake-regional group vs. 98.97 in general anesthesia group
  • Difference in means: 0.23 (95% CI: -2.59 to 3.06), providing strong evidence of equivalence 2
  • This finding held in both per-protocol and intention-to-treat analyses

The PANDA Trial (Pediatric Anesthesia NeuroDevelopment Assessment)

The PANDA trial was an ambi-directional sibling-matched cohort study comparing children who received general anesthesia for hernia repair before age 3 years versus their unexposed siblings 3, 4.

Study Design

  • Population: Sibling pairs where one had hernia repair under general anesthesia before age 3
  • Control: Matched sibling without anesthesia exposure
  • Outcome: Comprehensive neuropsychological battery

Key Results

  • No significant differences in IQ scores between exposed and unexposed siblings 3, 4
  • The sibling-matched design helped control for genetic and environmental confounding factors

Critical Interpretation and Clinical Context

What These Trials Tell Us

Both trials converge on a reassuring message: brief, single anesthetic exposures (approximately 1 hour) in otherwise healthy infants do not appear to cause measurable cognitive deficits at ages 2-5 years 5, 3, 1, 2, 4.

Important Caveats and Limitations

Duration and Frequency Matter:

  • These trials only assessed single, brief exposures (median ~54 minutes)
  • Evidence suggests multiple or prolonged exposures may carry increased risk 6, 7
  • A recent analysis from the GAS database found children with multiple anesthetic exposures scored almost 6 points lower on FSIQ compared to single or no exposure (mean difference: -5.8; 95% CI: -10.2 to -1.4) 7

Population Characteristics:

  • PANDA participants had high socioeconomic status and high baseline IQ scores, potentially limiting generalizability 3
  • Both trials predominantly included male infants undergoing hernia repair
  • Results may not reflect contemporary anesthesia practice as cohorts were born in 2000 or earlier 6

Timing of Assessment:

  • Cognitive deficits from preclinical studies may not manifest until later in life 3
  • Assessment at age 5 may miss subtle deficits that emerge during more complex academic demands

Confounding Factors:

  • Observational studies cannot fully exclude confounding from underlying disease, surgical complexity, and hospitalization 6, 8
  • Children requiring surgery may have pre-existing conditions contributing to outcomes 5

Emerging Evidence on Specific Outcomes

ADHD Risk: Several large population-based studies consistently identify a small increased risk of attention-deficit hyperactivity disorder following early general anesthesia exposure 8

Learning Disabilities: Low-certainty evidence suggests early childhood GA exposure is associated with increased risk of learning disabilities (RR=1.23,95% CI: 1.06-1.43), with no significant association for single exposures (RR=1.02) but significantly increased risk for multiple exposures (RR=2.29,95% CI: 1.72-3.05) 6

Clinical Recommendations

For Single, Brief Procedures:

  • Necessary surgery should not be delayed due to theoretical neurodevelopmental concerns 8
  • Current evidence supports proceeding with standard anesthetic care for brief, single exposures

For Multiple or Prolonged Exposures:

  • Consider strategies to minimize cumulative anesthetic exposure when feasible
  • Maintain physiological stability during anesthesia (avoid hypotension, hypoxia, hypoglycemia)
  • Discuss potential risks with families while emphasizing uncertainty and individual risk-benefit analysis

Communication with Families:

  • Acknowledge parental concerns about anesthesia and brain development
  • Emphasize that single, brief exposures appear safe based on current evidence
  • Explain that necessary procedures should not be delayed
  • Discuss that multiple or prolonged exposures may carry uncertain risks 8

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.